9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L., Kahan, Scott, Khunti, Kamlesh, Leon, Jose, Lyons, Sarah K., Perry, Mary Lou, Prahalad, Priya, Pratley, Richard E., Seley, Jane Jeffrie, Stanton, Robert C., Gabbay, Robert A.·2023·Diabetes Care

DOI 10.2337/dc23-s009

Cited by (852)

Items 101–200 of 852

Perspectives in weight control in diabetes - survodutide
Klein, Thomas, Augustin, Robert, Hennige, Anita M. · 2024 · Diabetes Research and Clinical Practice
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Osteopathy: Another Positive Effect of Incretines? A 12 Months Longitudinal Study
Antonella Fardus Al Refaie, Leonardo Baldassini, Caterina Mondillo, Elena Ceccarelli, Roberto Tarquini, Luigi Gennari, Stefano Gonnelli, Carla Caffarelli · 2024 · Calcified Tissue International
SGLT2 Inhibitors: Effect on Myocardial Infarction and Stroke in Type 2 Diabetes
Pradip Mukhopadhyay, Debmalya Sanyal, Purushottam Chatterjee, Kaushik Pandit, Sujoy Kumar Ghosh · 2023 · The Journal of Clinical Endocrinology & Metabolism
In praise of pioglitazone: An economically efficacious therapy for type 2 diabetes and other manifestations of the metabolic syndrome
David S.H. Bell, Terri W. Jerkins · 2023 · Diabetes Obesity and Metabolism
Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
HARPREET SINGH BAJAJ, LMC Diabetes & Endocrinology, Brampton, Ontario, Canada, Ronald M Goldenberg, LMC Diabetes & Endocrinology, Concord, Ontario, Canada · 2023 · touchREVIEWS in Endocrinology
Management of Residual Risk in Chronic Coronary Syndromes. Clinical Pathways for a Quality-Based Secondary Prevention
Simona Giubilato, Fabiana Lucà, Maurizio Giuseppe Abrignani, Laura Gatto, Carmelo Massimiliano Rao, Nadia Ingianni, Francesco Amico, Roberta Rossini, Giorgio Caretta, Stefano Cornara et al. · 2023 · Journal of Clinical Medicine
Epidemiology and Management of Hypertension and Diabetes Mellitus in Patients with Mild Autonomous Cortisol Secretion: A Review
Marta Araujo Castro, Martín Reincke, Cristina Lamas · 2023 · Biomedicines
Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study
Yunwen Xu, Thomas A. Boyle, Beini Lyu, Shoshana H. Ballew, Elizabeth Selvin, Alex R. Chang, Lesley A. Inker, Morgan Erika Grams, Jung‐Im Shin · 2024 · Journal of General Internal Medicine
Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Jianbo Guo, Chen Liu, Yifan Wang, Baoyi Shao, Tung Leong Fong, Ngai Chung Lau, Hui Zhang, Hai-Di Li, Jianan Wang, Xinyu Lu et al. · 2024 · EClinicalMedicine
Increasing Medication Use and Polypharmacy in Type 2 Diabetes: The Danish Experience From 2000 to 2020
Karl Sebastian Johansson, Espen Jimenez‐Solem, Tonny Studsgaard Petersen, Mikkel Christensen · 2024 · Diabetes Care
Pharmacotherapy before and after bariatric surgery
Khaled A. Alabduljabbar, Carel Wynand le Roux · 2023 · Metabolism
The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
Shang‐Chin Huang, Jia‐Horng Kao · 2023 · The Kaohsiung Journal of Medical Sciences
Association of Continued Use of SGLT2 Inhibitors From the Ambulatory to Inpatient Setting With Hospital Outcomes in Patients With Diabetes: A Nationwide Cohort Study
Lakshmi G. Singh, Spyridon Ntelis, Tariq Siddiqui, Stephen L. Seliger, John David Sorkin, Elias K. Spanakis · 2023 · Diabetes Care
GLP-1 receptor agonists
LaDonna Clark · 2024 · JAAPA
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Robert G. Krysiak, Hedi L. Claahsen‐van der Grinten, Nicole Reisch, Philippe A. Touraine, Henrik Falhammar · 2024 · Endocrine Reviews
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
Daniel R. Morales, Fan Bu, Benjamin Viernes, Scott L. DuVall, Michael Edwin Matheny, Katherine Simon, Thomas Falconer, Lauren R. Richter, Anna Ostropolets, Wallis C. Y. Lau et al. · 2025 · Diabetes Care
Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6
Klein, Klara R., Clemmensen, Kim K.B., Fong, Edwin, Olsen, Søren, Abrahamsen, Trine, Lingvay, Ildiko · 2024 · Diabetes Care
Pioglitazone as Add-on Therapy in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial
Ji Hye Heo, Kyung Ah Han, Jun Hwa Hong, Hyun-Ae Seo, Eun‐Gyoung Hong, Jae Myung Yu, Hye Seung Jung, Bong Soo · 2024 · Diabetes & Metabolism Journal
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
Rikke Viggers, Nicklas H. Rasmussen, Peter Vestergaard · 2023 · JBMR Plus
Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus
Shunichiro Tsukamoto, Shohei Tanaka, Takayuki Yamada, Kazushi Uneda, Kengo Azushima, Sho Kinguchi, Hiromichi Wakui, Kouichi Tamura · 2023 · Diabetes Obesity and Metabolism
Real‐world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study ( ENDO 2 S‐RWD )
Óscar Moreno, Rebeca Reyes‐García, Inés Modrego Pardo, Viyey Kishore Doulatram‐Gamgaram, Carlos Casado Cases, Cristina Guillen‐Morote, Nieves Arias Mendoza, Cristina Tejera Pérez, Jersy Cárdenas‐Salas, Sandra Martínez‐Fuster et al. · 2023 · Diabetes Obesity and Metabolism
A multicentre, double‐blind, placebo‐controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add‐on therapy in type 2 diabetic patients treated with metformin and dapagliflozin
Soo Kyung Lim, Seung‐Hwan Lee, Kyung‐Wan Min, Chang Beom Lee, Sang Yong Kim, Hye Jin Yoo, Nan Hee Kim, Jae Hyeon Kim, Seungjoon Oh, Jong Chul Won et al. · 2024 · Diabetes Obesity and Metabolism
Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood
Stacey L. Simon, Phoutdavone Phimphasone‐Brady, Kathryn M. McKenney, Lauren D. Gulley, Andrea Elena Bonny, Jaime M. Moore, Carla Torres-Zegarra, Melanie Cree‐Green · 2024 · The Lancet Child & Adolescent Health
Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature
Lampros Chrysavgis, Spyridon Kazanas, Konstantina Bafa, Sofia Rozani, Maria Evangelia Koloutsou, Εvangelos Cholongitas · 2024 · International Journal of Molecular Sciences
Real-World Impact of GLP-1 Receptor Agonists on Endoscopic Patient Outcomes in an Ambulatory Setting: A Retrospective Study at a Large Tertiary Center
Ernesto Robalino Gonzaga, Aimen Farooq, Abdul Mohammed, Saurabh Chandan, Baha Aldeen Bani Fawwaz, Gurdeep Singh, Amna Malik, Yiyang Zhang, Kambiz S. Kadkhodayan · 2024 · Journal of Clinical Medicine
Effectiveness and Safety of GLP-1 Receptor Agonists in Patients with Type 1 Diabetes
Sumaya N. Almohareb, Osamah M. Alfayez, Shoroq S. Aljuaid, Walaa A Alshahrani, Ghalia H Bakhsh, Mohammed Kanan Alshammari, Majed S. Al Yami, Omar A. Alshaya, Abdullah S. Alomran, Ghazwa B. Korayem et al. · 2024 · Journal of Clinical Medicine
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
Chin‐Feng Hsuan, Sean I. F. Teng, Chih‐Neng Hsu, Daniel Liao, Allen Jiun-Wei Chang, Hsiao-Lin Lee, Siow‐Wey Hee, Yi‐Cheng Chang, Lee‐Ming Chuang · 2023 · Biomedicines
Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
Casey Berman, Alaina P. Vidmar, Lily C. Chao · 2023 · touchREVIEWS in Endocrinology
Sodium-Glucose Cotransporter 2 Inhibitors vs Incretin-Based Drugs and Risk of Fractures for Type 2 Diabetes
Hwa Yeon Ko, Sungho Bea, Han Eol Jeong, Sohee Park, Young Min Cho, Sung Hye Kong, Ju‐Young Shin · 2023 · JAMA Network Open
Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value
Tomás González‐Vidal, Diego Rivas‐Otero, Alba Gutiérrez-Hurtado, Carlos Alonso Felgueroso, Gema Martínez Tamés, Carmen Lambert, Elías Delgado, Edelmiro Luis Menéndez Torre · 2023 · Diabetology & Metabolic Syndrome
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes
Edouard L. Fu, Julianna M. Mastrorilli, Katsiaryna Bykov, Deborah J. Wexler, Alexander Cervone, Kueiyu Joshua Lin, Elisabetta Patorno, Julie M. Paik · 2023 · Kidney International
Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats
Nika Farrokh-Eslamlou, Saeideh Momtaz, Amirhossein Niknejad, Yasamin Hosseini, Parvin Mahdaviani, Morteza Ghasemnejad‐Berenji, Amir Hossein Abdolghaffari · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
Perioperative Glycemic Management in Cardiac Surgery: A Narrative Review
Yada Thongsuk, Nian Chih Hwang · 2023 · Journal of Cardiothoracic and Vascular Anesthesia
Deep Reinforcement Learning for Automated Insulin Delivery Systems: Algorithms, Applications, and Prospects
Xia Yu, Zi Yang, Xiaoyu Sun, Hao Liu, Hongru Li, Jingyi Lu, Jian Hua Zhou, Ali Çınar · 2025 · AI
Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: A population-based study of Northern Italy
Andreana Foresta, Elena Succurro, Marta Baviera, Giulia Macaluso, Maria Luisa Ojeda Fernandez, Maria Carla Roncaglioni, Ida Fortino, Alessandro Nobili, Giorgio Sesti · 2023 · Diabetes Research and Clinical Practice
Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach
Javier Morales, Samuel E. Dagogo-Jack, Vivian Andrew Fonseca, Joshua J. Neumiller, Sylvia E. Rosas · 2023 · Clinical Diabetes
Role of metformin in the management of type 2 diabetes: recent advances
Carolina Gonzalez-Lopez, Brian S. Wojeck · 2023 · Polskie Archiwum Medycyny Wewnętrznej
Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24‐week, randomized, double‐blind, placebo‐controlled trial
Yuan‐Di C. Halvorsen, Annie L. Conery, John Paul Lock, Wenjiong Zhou, Mason Wright Freeman · 2023 · Diabetes Obesity and Metabolism
Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis
Gangfeng Li, Shuping Zhong, Xingmu Wang, Fuyuan Zhuge · 2023 · Frontiers in Endocrinology
Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study
Zi‐Yang Peng, Chun-Ting Yang, Wei‐Hung Lin, Wenyu Yao, Huang‐Tz Ou, Shihchen Kuo · 2023 · Cardiovascular Diabetology
Combination Therapy of Endoscopic Gastric Remodeling with GLP-1RA for the Treatment of MASLD
Pichamol Jirapinyo, Aunchalee Jaroenlapnopparat, Stephen D. Zucker, Christopher C. Thompson · 2024 · Obesity Surgery
Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
Ssu‐Yu Pan, En-Lin Su, Chi‐Jung Huang, Shao‐Yuan Chuang, Chern‐En Chiang, Chen‐Huan Chen, Hao‐Min Cheng · 2024 · Age and Ageing
Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly—Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying
Parkman, Henry P., Rim, Daniel S., Anolik, Jonathan R., Dadparvar, Simin, Maurer, Alan H. · 2024 · Journal of Nuclear Medicine Technology
Prevalence of adherence to oral antidiabetic drugs in patients with type 2 diabetes: A systematic review and meta‐analysis
Kansak Boonpattharatthiti, Pirune Na Songkla, Junpen Chantara, Chanchanok Koomsri, Ines Krass, Nathorn Chaiyakunapruk, Teerapon Dhippayom · 2024 · Journal of Diabetes Investigation
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes
Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruíz, María Rosa Fernández Olmo, Carlos Morillas Ariño, Juan José Gómez‐Doblas, José Luis Górriz, Pilar Mazón‐Ramos, Xavier García–Moll, María José Soler et al. · 2023 · Journal of Clinical Medicine
Discovery of novel flavonoid derivatives as potential dual inhibitors against α-glucosidase and α-amylase: virtual screening, synthesis, and biological evaluation
Tan Thanh Mai, Minh-Hoang Phan, Thao Thi Thai, Thua-Phong Lam, Nghia Vo-Trong Lai, Thanh-Thao Nguyen, Thuy-Viet-Phuong Nguyen, Cam-Van Thi Vo, Khac‐Minh Thai, Thanh‐Dao Tran · 2023 · Molecular Diversity
Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis
Hani Raka Karrar, Mahmoud Ismail Nouh, Yousef Ismail Nouh, Mawadah Ismaeel Nooh, Adel S Khan Alhindi, Yousef Hassan Hemeq, Abdullah Mohammed S Aljameeli, Jameel Abdullah Aljuaid, Saleh Jabbar Alzahrani, Abdullah Abdulrahman Alsatami et al. · 2023 · Cureus
SGLT2 Inhibitors to Slow Chronic Kidney Disease Progression: A Review
Rebecca Maxson, Jessica A. Starr, Jeanna Sewell, Claretha Lyas · 2023 · Clinical Therapeutics
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression
Michael W. Holliday, Livia Ann Frost, Sankar Dass Navaneethan · 2024 · Current Opinion in Nephrology & Hypertension
Overweight and Obesity in People Living With Type 1 Diabetes: A Cross‐Sectional Analysis of the BETTER Registry
Marie‐Laure Lalanne‐Mistrih, Anne Bonhoure, Virginie Messier, Valérie Boudreau, Maha Lebbar, Meryem Khadija Talbo, Cathy Sun, Aude Bandini, Laurence Secours, Virginie Calderon et al. · 2024 · Diabetes/Metabolism Research and Reviews
SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease
Paulo André Bispo Machado Júnior, André Domingos Lass, Bruna Isadora Pilger, Raphaella Fornazari, Thyago Proença de Moraes, Ricardo A. Pinho · 2024 · Brazilian Journal of Nephrology
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross‐sectional study
Leili Gao, Xingwu Ran, Xuejun Liu, Xingping Shen, Shuchun Chen, Fuqiang Liu, Dong Zhao, Yan Bi, Qing Su, Yao Lu et al. · 2023 · Journal of Diabetes
The Role of Autophagy in Type 2 Diabetic Kidney Disease Management
Che-Hao Tseng, Kavya M. Shah, I‐Jen Chiu, Li‐Li Hsiao · 2023 · Cells
Effectiveness and safety of empagliflozin: final results from the EMPRISE study
Phyo Than Htoo, Helen Tesfaye, Sebastian Schneeweiß, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz‐Luyet, Julie M. Paik et al. · 2024 · Diabetologia
Cardiovascular Risk Factor Management After Hypertensive Disorders of Pregnancy
Jennifer Lewey, M. Sheehan, N. Bello, Lisa D. Levine · 2024 · Obstetrics and Gynecology
Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study
Yun Kyung Cho, Kyung Soo Kim, Byung‐Wan Lee, Jun Hwa Hong, Jae Myung Yu, Soo Kyung Lim, Ye An Kim, Chang Beom Lee, Sang Soo Kim, Soo Heon Kwak et al. · 2024 · Clinical Therapeutics
Semaglutide, a glucagon-like peptide-1 receptor agonist, inhibits oral squamous cell carcinoma growth through P38 MAPK signaling pathway
Can Wang, Zhengzheng Wu, Jiaying Zhou, Bin Cheng, Yulei Huang · 2025 · Journal of Cancer Research and Clinical Oncology
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
Vincenzo Trapanese, Annamaria Dagostino, Maria Resilde Natale, Federica Giofrè, Clara Vatalaro, Melania Melina, Francesca Cosentino, Silvia Sergi, Felice Imoletti, Rocco Spagnuolo et al. · 2025 · Life
One third of cases of new‐onset diabetic ketosis in adults are associated with ketosis‐prone type 2 diabetes—A systematic review and meta‐analysis
Adrienn Kovacs, Ștefania Bunduc, Dániel Sándor Veres, Dániel Pálinkás, Endre Botond Gagyi, Péter Hegyi, Bálint Mihály Erőss, Emese Mihály, Péter Jenő Hegyi, Nóra Hosszúfalusi · 2023 · Diabetes/Metabolism Research and Reviews
Metformin-associated Lactic Acidosis Induced by Excessive Alcohol Consumption
Hirofumi Yamagishi, Naoki Sekiguchi, Akiko Hirano, Atsushi Oshima, Taihei Imai · 2023 · Internal Medicine
Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials
Lu Chen, Qingxia Xue, Chunyan Yan, Bingying Tang, Lu Wang, Bei Zhang, Quan Zhao · 2023 · Frontiers in Endocrinology
Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986–2019
T. Anders Olsen, Reed F. Beall, Ryan P. Knox, S. Sean Tu, Aaron Seth Kesselheim, William B. Feldman · 2023 · PLoS Medicine
Diabetic Kidney Disease Prevention Care Model Development
Nuha A. ElSayed, Raveendhara R. Bannuru, George L. Bakris, Joan K. Bardsley, Ian H. de Boer, Robert A. Gabbay, Janet P. Gockerman, Rozalina G. McCoy, Elaine McCracken, Joshua J. Neumiller et al. · 2023 · Clinical Diabetes
Glycaemic control efficacy of switching from dipeptidyl peptidase‐4 inhibitors to oral semaglutide in subjects with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study ( SWITCH‐SEMA 2 study)
Sho Furusawa, Hiroshi Nomoto, Hiroki Yokoyama, Yuka Suzuki, Atsushi Tsuzuki, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi et al. · 2023 · Diabetes Obesity and Metabolism
Glucagon-Like Peptide 1 (GLP-1) Receptor Variants and Glycemic Response to Liraglutide: A Pharmacogenetics Study in Iranian People with Type 2 Diabetes Mellitus
Maryam Eghbali, Fariba Alaei-Shahmiri, Nahid Hashemi‐Madani, Zahra Emami, Ladan Mostafavi, Mojtaba Malek, Mohammad E. Khamseh · 2024 · Advances in Therapy
Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial
Konstantin Alexander Krychtiuk, Guillaume Marquis‐Gravel, Shannon Murphy, Karen P. Alexander, Karen Chiswell, Jennifer B. Green, Lawrence A. Leiter, Renato D. Lópes, Stefano Del Prato, W. Schuyler Jones et al. · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study
Yu‐Chi Su, Pei-Chun Hsieh, Edward Chia‐Cheng Lai, Yu-Ching Lin · 2024 · Diabetes & Metabolism
Management of kidney transplant recipients for primary care practitioners
Manal E. Alotaibi, Brandon L. Trollinger, Sam Kant · 2024 · BMC Nephrology
Efficacy of a Digital Educational Intervention for Patients With Type 2 Diabetes Mellitus: Multicenter, Randomized, Prospective, 6-Month Follow-Up Study
Irene Caballero Mateos, Cristóbal Morales, María Laínez López, Ángel Vilches‐Arenas · 2025 · Journal of Medical Internet Research
Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment
Jose Alejandro Luchsinger, Davangere P. Devanand, Terry E. Goldberg, Sam Cammack, Gabriela Hernández-Santiago, Kenichi Oishi, William Jagust, Suzanne L. Baker, Susan M. Landau, Gayane Yenokyan et al. · 2025 · Alzheimer Disease & Associated Disorders
Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
Charalampos Milionis, Ιoannis Ilias, Evangelia Venaki, Eftychia G. Koukkou · 2023 · Biomedicines
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Kamlesh Khunti, Mussa Almalki, Juliana C.N. Chan, Aslam Amod · 2023 · Diabetes Therapy
Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling
Ehab Bakbak, Subodh Verma, Aishwarya Krishnaraj, Adrian Quan, Chao‐Hung Wang, Yi Pan, Pankaj Puar, Tamique Mason, Raj Verma, Daniella C. Terenzi et al. · 2023 · American Journal of Physiology-Heart and Circulatory Physiology
Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic Outcomes
Carly J. Paoli, Jörg Linder, Khushboo Gurjar, Deepika Thakur, Julie Wyckmans, Stacy Grieve · 2024 · Journal of health economics and outcomes research
Innovative freeze-drying technique in the fabrication of dissolving microneedle patch: Enhancing transdermal drug delivery efficiency
Tong Su, Zequn Tang, Jiayi Hu, Yuyu Zhu, Teng Shen · 2024 · Drug Delivery and Translational Research
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges
Mahmoud Emad-Eldin, Gehan Fathy Balata, E el-Shorbagy, Mona S. Hamed, Mohamed S Attia · 2024 · World Journal of Diabetes
Barriers to early diagnosis of chronic kidney disease and use of sodium‐glucose cotransporter‐2 inhibitors for renal protection: A comprehensive review and call to action
Leszek Czupryniak, Ofri Mosenzon, Ivan Rychlík, Martin Clodi, Fahim Ebrahimi, Andrej Janež, Péter Kempler, Maciej Tadeusz Malecki, Evgeny Moshkovich, Martin Prázný et al. · 2024 · Diabetes Obesity and Metabolism
Metabolomic Fingerprints of Medical Therapy Versus Bariatric Surgery in Patients With Obesity and Type 2 Diabetes: The STAMPEDE Trial
Christopher L. Axelrod, Adithya Hari, Wagner S. Dantas, Sangeeta Rao Kashyap, Philip R. Schauer, John P. Kirwan · 2024 · Diabetes Care
Cardiovascular prevention with glucose‐lowering drugs in type 2 diabetes: An evidence‐based approach to the categories of primary and secondary prevention
Mannucci, Edoardo, Silverii, Giovanni Antonio · 2023 · Diabetes, Obesity and Metabolism
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes
Yunha Noh, Hui Yin, Oriana Hoi Yun Yu, Alain Bitton, Laurent Azoulay · 2025 · Annals of Internal Medicine
Initiation of iGlarLixi Versus Basal-Bolus Insulin in Adults With Type 2 Diabetes Advancing From Basal Insulin Therapy: The SoliComplex Real-World Study
Kevin M. Pantalone, Caroline G. Heller, Rosemarie Lajara, Elisheva Lew, Xuan Li, TERRY A. DEX, C. Rachel Kilpatrick · 2023 · Diabetes Spectrum
Study design and baseline profile for adults with type 2 diabetes in the once-weekly subcutaneous SEmaglutide randomized PRAgmatic (SEPRA) trial
John B. Buse, Helene Nordahl Christensen, Brian J Harty, Julie Mitchell, Benjamin P. Soule, Emily W. Zacherle, Mark J. Cziraky, Vincent J. Willey · 2023 · BMJ Open Diabetes Research & Care
Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes
Carolina Solis‐Herrera, Curtis L. Triplitt · 2023 · Diabetes Obesity and Metabolism
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes
Thomas Karagiannis, Απόστολος Τσάπας, Eleni Bekiari, Konstantinos A. Toulis, Michael Albrecht Nauck · 2024 · Diabetes Care
The possible effect of anti-diabetic agents GLP-1RA and SGLT-2i on the respiratory system function
Kanella Kantreva, Paraskevi A Katsaounou, Katerina Saltiki, Georgia Trakada, Georgia Ntali, Theodora Stratigou, Marinella Tzanela, Θεοδώρα Ψαλτοπούλου, Stavroula Α. Paschou · 2024 · Endocrine
Efficacy of anti-obesity medication (AOM) and endoscopic gastric remodeling (EGR): Analysis of combination therapy with optimal timing and agents
Pichamol Jirapinyo, Aunchalee Jaroenlapnopparat, Christopher C. Thompson · 2024 · Endoscopy International Open
Evaluating GLP-1 receptor agonists versus metformin as first-line therapy for reducing dementia risk in type 2 diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, Yi Yang, Shuang Lv, Mengrong Miao, Wanming Chen, Szu‐Yuan Wu, Jiaqiang Zhang · 2025 · BMJ Open Diabetes Research & Care
Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy
Antonio Cutruzzolà, Adriano Carnevali, Valentina Gatti, Giovanni Latella, Luca Lamonica, Flavia Oliverio, Massimo Borelli, Martina Parise, Sergio Di Molfetta, Vincenzo Scorcia et al. · 2023 · Journal of Diabetes Research
The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review
André Jacques Scheen · 2023 · Expert Review of Endocrinology & Metabolism
Neonatal outcomes and rationale for timing of birth in perinatal diabetes: a retrospective cohort study
Sereen K. Nashif, Renee M. Mahr, Katelyn Tessier, Elizabeth A. Hoover, Oluwabukola Akingbola, Emily Chiu, Janet I. Andrews, Bethany Sabol, William Kirke Rogers, Sarah A. Wernimont · 2023 · American Journal of Obstetrics & Gynecology MFM
Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA
Julie C. Lauffenburger, Helen Tesfaye, Daniel H. Solomon, Elliott Marshall Antman, Robert J. Glynn, Su Been Lee, Angela Tong, Niteesh K. Choudhry · 2023 · BMJ Open
Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials
Tanawan Kongmalai, Phorntida Hadnorntun, Pattara Leelahavarong, Pinkawas Kongmalai, Varalak Srinonprasert, Srisakul Chirakarnjanakorn, Usa Chaikledkaew, Gareth J. McKay, John Attia, Ammarin Thakkinstian · 2023 · Frontiers in Endocrinology
Real-World Effectiveness of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists (OW GLP-1RAs) in Comparison with Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) for Glycemic Control and Weight Outcomes in Type 2 Diabetes Mellitus (RELATE)
Xi Tan, Victoria M. Divino, James J. Amamoo, Lin Xie, Katharine B. Coyle, Cory L. Gamble, Mico Guevarra, Yurek Paprocki, Aaron A. King · 2024 · Clinical Drug Investigation
Assessment of Cardiovascular Risk Categories and Achievement of Therapeutic Targets in European Patients with Type 2 Diabetes
Delia Reurean‐Pintilei, Claudia-Gabriela Potcovaru, Teodor Salmen, Liliana Mititelu-Tarțău, Delia Cinteză, Sandra Lazăr, Anca Pantea Stoian, Romulus Zorin Timar, Bogdan Timar · 2024 · Journal of Clinical Medicine
Trends in Number and Appropriateness of Prescription Medication Utilization Among Community-Dwelling Older Adults in the United States: 2011–2020
Shaoxi Pan, Shanshan Li, Shaoxiang Jiang, Jung‐Im Shin, Gordon G. Liu, Hongyan Wu, Beini Lyu · 2024 · The Journals of Gerontology Series A
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study
Yu Jiang, Luyao Wang, Zhenhua Dong, Baotian Xia, Shuguang Pang · 2024 · Journal of Diabetes
Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania
Teodor Salmen, Valeria-Anca Pietroșel, Delia Reurean‐Pintilei, Mihaela Adela Iancu, Radu-Cristian Cîmpeanu, Ioana-Cristina Bica, Roxana-Ioana Dumitriu-Stan, Claudia-Gabriela Potcovaru, Bianca-Margareta Salmen, Camelia Cristina Diaconu et al. · 2024 · Pharmaceuticals
The role of multimodality imaging in diabetic cardiomyopathy: a brief review
Fadi Adel, Horng H. Chen · 2024 · Frontiers in Endocrinology
Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes
Fu‐Shun Yen, Yao‐Min Hung, Jing‐Yang Huang, Chih‐Cheng Hsu, Wan‐Yin Cheng, Chii‐Min Hwu, James Cheng‐Chung Wei · 2025 · Journal of Internal Medicine
Metformin impairs trophoblast metabolism and differentiation in a dose-dependent manner
Sereen K. Nashif, Renee M. Mahr, Snehalata Jena, Seokwon Jo, Alisa B. Nelson, Danielle Sadowski, Peter A. Crawford, Patrycja Puchalska, Emilyn U. Alejandro, Micah D. Gearhart et al. · 2023 · Frontiers in Cell and Developmental Biology